Digital Health Outcomes at ISPOR 19th Annual European Congress

Interested to learn more about interactive health data visualizations, digital tools and communication interfaces for HEOR models ?

We welcome ISPOR participants to meet us at our booth #512. We will be presentation our latest works, budget impact and cost-effectiveness models for iPad/Web, interactive health data visualizations and tools/platforms for value story delivery and communication.

Please come by our booth if you are interested to know more !

Digital Health Outcomes team

 

 

 

Health Economics and Outcomes Research (HEOR)

HEOR is a field of Economic Evaluations of Healthcare Technologies

Health Economics and Outcomes Research (HEOR) is an area of economic analyses that deals with the studies and mathematical models (simulations) based on available clinical, epidemiological, economic data and published evidence to inform rational and evidence based decision making. HEOR deals with allocation of funds for healthcare purchasing,  evaluations of the value for money of healthcare technologies, drugs and medical devices in order to inform budgeting and change in clinical practice decisions. Healthcare payers (government, insurance companies, hospitals) operating under constrained budgets are always seeking to maximise the output (value, health, procedures) subject to limited financial resources and other constraints (technical, time, legal, management changes).

Read More

Payer engagement apps and tools for pharmaceutical and medical devices market access

Pharma and medical devices companies put a lot of effort into development of their product value story. The value story often takes a form of an MS Excel file or a Power Point deck containing detailed information on burden of illness, product profile, clinical differentiators and health outcomes.

The question is – do these conventional document formats communicate product value story effectively ? Most probably not. With modern digital tools Key Account Managers (KAM) and Medical Science Liaisons (MSL) can present health data and evidence to payers and healthcare providers more effectively.

Read More

Meet Digital Health Outcomes at 21st international ISPOR in Washington DC

Modern ways of presenting evidence, data and models in an interactive digital format. Interested to learn more? Please join us at our booth #TT3 (Concourse Level) during ISPOR in DC.

We are keen to share our experience with the cutting edge data visualisation tools and latest web techs that maximise the impact of health economic models and value story. Our experts will be happy to answer any questions you might have regarding the choice of appropriate software techs, tools and data visualisation methods.

Check out our latest blog article on best practices to data visualisation and interactive storytelling: http://bit.ly/1OzbD8i

Looking forward to seeing you at the conference !

Digital Health Outcomes team

Interactive health data visualization approaches: good practices and examples

How interactive data visualizations change communication of health data

Presentation of health data is undergoing a big change, one that will influence not only how payers and providers make their decisions but also how pharma, medical devices and in-vitro diagnostics companies will interact with external world. Five years ago, interactive health data visualisations usually took a form of simple dashboards with animated charts and accompanying messages.

Nowadays evolutions of modern web capabilities and emergence of the powerful data visualisation tools open almost unlimited possibilities to visualise data and tell the complex story in an easy to digest manner.

Read More

Digital Health Outcomes at European ISPOR in Milan

ispor-milan-2016

 

Digital Health Outcomes presented publicly services and technologies at ISPOR 2016 in Milan. We’d like to thank all our partners for support and ongoing collaboration. We look forward for new opportunities in 2016 !

During a 3 day conference were were exposed to a lot of interest from the side of pharmaceutical producers and consulting sector. A lot of conference participants were interested in a new approaches to data visualisations and interactive storytelling. We appreciate the dataviz movement is growing within a healthcare  and life sciences industries. Effective data communications is a crucial step in market access. Pharmaceutical producers spend millions of dollars to develop robust and strong clinical evidence, but don’t communicate findings in the most effective manner. Our role and goal is to power credible data with modern data visulaizaion appraoces tools and libraries to convey health evidence in the most effective way.

Big Data hype or how not to get into a trap

The ‘big data’ matter has lately been widely discussed within the various businesses and industries, such as IT,  chemical, pharmaceutical, metallurgical, financial, oil and gas, consumer, high technology, retail etc. No wonder it even managed to create a significant hype, the promises of big data acquisitions are very tempting, but the failure rate is high as well.

We tried to analyze different researches regarding ‘big data’ and form our own opinion on the subject.

Read More

Budget Impact Model app for iPad and Web – an effective tool for payer engagement

iPad budget impact model apps – communication tools for engagement with payers and prescribers

Live tool example

Budget Impact Model (BIM) is the health economics type of model which calculates the net cost of including a new drug or therapy into certain healthcare system or payer, hospital settings. Budget impact model app (budget impact analysis) quantifies the financial impact of a new therapy (drug, medical device, vaccine) for a decision maker (payer), thus allowing pharmaceutical and medical device companies to clearly and persuasively communicate the product cost and clinical value. It is accomplished through measuring the net cumulative cost of particular drug or therapy for a specific number of patients, with at least two (including and excluding the product in question) comparative scenarios.

Read More